OmicsX

OmicsX was established in 2010, as a subsidiary of HH BioTechnologies Pvt. Team OmicsX designed and publish NSCLC Gene Regulatory Networks using 100+ lung cancer patients high throughput omic data and put forward three unexplored cancer drug targets. Since 2012, we are closely monitoring and mapping scientific and business activities, for the largest number of active Drug Developers worldwide, with nearly equal number of clinical research companies supporting them. We are a team of like-minded people, with an aims to create perfectly crafted ready to implement drug discovery market intelligence solutions. We at OmicsX provides an instant, ready to use solutions to ease your routine tasks and helping your team to stay ahead and updated. We are regularly publishing quality market intelligence reports from past more than a decade, with deep expertise on complete coverage and factual data presentation. We at OmicsX offers regular services to maintain and timely update the CRMS entries as well as if required add desired additional new data feeds/points to get maximum outcome from your existing database. We published our first commercial report in 2013 on Oncology Drug Intelligence which provides comprehensive knowledge; and was very much appreciated, and was the first small attempt to put forward the holistic view on cancer drug discovery.